Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New genomics tool boosts diabetes research

27.02.2004


Researchers have developed a method for scanning the entire human genome to successfully map the location of key gene regulators, mutated forms of which are known to cause type 2 diabetes. The research marks the first time that human organs, in this case the pancreas and liver, have been analyzed in this way and opens the door to similar studies of other organ systems and diseases.



The work, published in the Feb. 27 issue of the journal Science, could lead to new approaches for developing medications and assessing a person’s genetic risk to this and other conditions, says Richard Young, a scientist at Whitehead Institute for Biomedical Research and lead researcher on the project.

Key to understanding the relationship between genes and disease are gene regulators called transcription factors, proteins that bind to specific areas of the genome and act to switch genes on and off. To discover how a specific transcription factor might contribute to a particular disease, scientists must locate each point in the genome where the transcription factor adheres and identify the individual genes it controls. Using conventional tools, it might take a single scientist a lifetime to do this for just one transcription factor. Yet humans have over 1,000 transcription factors and dozens of these have been linked to diseases.


"We developed an efficient gene-scanning technology so we could map genome binding sites for many transcription factors in a human organ," says Duncan Odom, a postdoctoral fellow at Whitehead Institute and lead author of the paper. "This allows us to identify the sets of genes where transcription factors act as switches and to learn how defects in these switches might cause disease".

In October 2002, a team led by Young, who also is a professor of biology at Massachusetts Institute of Technology, reported in Science on a technology used to identify how over 100 transcription factors were associated with the yeast genome, reducing the amount of time it would ordinarily take to do this from centuries to months. In this new study, Young’s team demonstrates that a modified version of this technology also can be used to scan human tissue.

The researchers applied this technology to several transcription factors that reside in the pancreas and liver and were known to be associated with type 2 diabetes, but just how they contributed to the disease was unknown. They discovered that one of the transcription factors, called HNF4, controls about half of all the genes needed to make the pancreas and liver. This suggests that without HNF4, these organs could not function normally, which is particularly relevant to diabetes because the pancreas produces insulin and loss of insulin production causes the disease.

HNF4 seems to contain many of the mutations that predispose a person to type 2 diabetes, the scientists say. "This new evidence explains why defects in the HNF4 transcription factor can lead to diabetes," says Young. "Even a small loss of HNF4 function could affect the health of the pancreas because this regulator is associated with so many important genes in this organ."

Now that we understand HNF4’s role, Young suggests researchers might be able to develop medications that modify the activities of mutated forms of HNF4, which could possibly prevent diabetes in some at-risk individuals. Also, these findings could enable scientists to create methods for analyzing an individual’s genetic profile to determine exactly that person’s risk level.

"This really changes your whole perspective," says Graeme Bell, professor of biochemistry and molecular biology at University of Chicago and co-author on the paper. "Before we were just looking at these conditions one gene at a time. Now we can see the whole playing field, and more importantly, we can see the players."

These findings go beyond diabetes and offer a whole new way of approaching research on many diseases, Young adds. "There are many human diseases associated with mutations in transcription factors, including cancer, hypertension and immunological and neurological disorders. Discovering how transcription factors regulate genes in various human organs should continue to provide clues to the causes of disease and offer new approaches for therapy."


Reporters may receive a copy of the journal article by contacting Science at scipak@aaas.org.

David Cameron | EurekAlert!
Further information:
http://www.wi.mit.edu/home.html

More articles from Life Sciences:

nachricht Sensory Perception Is Not a One-Way Street
17.10.2018 | Eberhard Karls Universität Tübingen

nachricht Sex or food? Decision-making in single-cell organisms
17.10.2018 | Max-Planck-Institut für chemische Ökologie

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Goodbye, silicon? On the way to new electronic materials with metal-organic networks

Scientists at the Max Planck Institute for Polymer Research (MPI-P) in Mainz (Germany) together with scientists from Dresden, Leipzig, Sofia (Bulgaria) and Madrid (Spain) have now developed and characterized a novel, metal-organic material which displays electrical properties mimicking those of highly crystalline silicon. The material which can easily be fabricated at room temperature could serve as a replacement for expensive conventional inorganic materials used in optoelectronics.

Silicon, a so called semiconductor, is currently widely employed for the development of components such as solar cells, LEDs or computer chips. High purity...

Im Focus: Storage & Transport of highly volatile Gases made safer & cheaper by the use of “Kinetic Trapping"

Augsburg chemists present a new technology for compressing, storing and transporting highly volatile gases in porous frameworks/New prospects for gas-powered vehicles

Storage of highly volatile gases has always been a major technological challenge, not least for use in the automotive sector, for, for example, methane or...

Im Focus: Disrupting crystalline order to restore superfluidity

When we put water in a freezer, water molecules crystallize and form ice. This change from one phase of matter to another is called a phase transition. While this transition, and countless others that occur in nature, typically takes place at the same fixed conditions, such as the freezing point, one can ask how it can be influenced in a controlled way.

We are all familiar with such control of the freezing transition, as it is an essential ingredient in the art of making a sorbet or a slushy. To make a cold...

Im Focus: Micro energy harvesters for the Internet of Things

Fraunhofer IWS Dresden scientists print electronic layers with polymer ink

Thin organic layers provide machines and equipment with new functions. They enable, for example, tiny energy recuperators. In future, these will be installed...

Im Focus: Dynamik einzelner Proteine

Neue Messmethode erlaubt es Forschenden, die Bewegung von Molekülen lange und genau zu verfolgen

Das Zusammenspiel aus Struktur und Dynamik bestimmt die Funktion von Proteinen, den molekularen Werkzeugen der Zelle. Durch Fortschritte in der...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Conference to pave the way for new therapies

17.10.2018 | Event News

Berlin5GWeek: Private industrial networks and temporary 5G connectivity islands

16.10.2018 | Event News

5th International Conference on Cellular Materials (CellMAT), Scientific Programme online

02.10.2018 | Event News

 
Latest News

Robot-assisted sensor system for quality assurance of press-hardened components

17.10.2018 | Trade Fair News

Sensory Perception Is Not a One-Way Street

17.10.2018 | Life Sciences

Plant Hormone Makes Space Farming a Possibility

17.10.2018 | Agricultural and Forestry Science

VideoLinks
Science & Research
Overview of more VideoLinks >>>